We assessed the potential of IL-38 to serve as a biomarker of RA and discovered that the concentration of serum IL-38 was significantly higher in the test group than in the control group (559.36 pg/mL vs 135.67 pg/mL). The gene discussed is IL1F10; the disease is rheumatoid arthritis.